Report Summary
It is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis
The global Crisaborole market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Crisaborole market based on company, product type, end user and key regions.
This report studies the global market size of Crisaborole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Crisaborole in these regions.
This research report categorizes the global Crisaborole market by top players/brands, region, type and end user. This report also studies the global Crisaborole market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Tapi Teva
Neuraxpharm
VIRUJ PHARMA
Synergy Pharmaceutical
Ausun Pharmaceutical
Market size by Product
Purity ? 98%
Purity ? 98%
Market size by End User
Allergic Dermatitis
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Crisaborole market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Crisaborole market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Crisaborole companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Crisaborole submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Crisaborole are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Crisaborole market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Crisaborole Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Crisaborole Market Size Growth Rate by Product
1.4.2 Purity ? 98%
1.4.3 Purity ? 98%
1.5 Market by End User
1.5.1 Global Crisaborole Market Size Growth Rate by End User
1.5.2 Allergic Dermatitis
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Crisaborole Market Size
2.1.1 Global Crisaborole Revenue 2017-2027
2.1.2 Global Crisaborole Sales 2017-2027
2.2 Crisaborole Growth Rate by Regions
2.2.1 Global Crisaborole Sales by Regions
2.2.2 Global Crisaborole Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Crisaborole Sales by Manufacturers
3.1.1 Crisaborole Sales by Manufacturers
3.1.2 Crisaborole Sales Market Share by Manufacturers
3.1.3 Global Crisaborole Market Concentration Ratio (CR5 and HHI)
3.2 Crisaborole Revenue by Manufacturers
3.2.1 Crisaborole Revenue by Manufacturers (2017-2020)
3.2.2 Crisaborole Revenue Share by Manufacturers (2017-2020)
3.3 Crisaborole Price by Manufacturers
3.4 Crisaborole Manufacturing Base Distribution, Product Types
3.4.1 Crisaborole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Crisaborole Product Type
3.4.3 Date of International Manufacturers Enter into Crisaborole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Crisaborole Sales by Product
4.2 Global Crisaborole Revenue by Product
4.3 Crisaborole Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Crisaborole Breakdown Data by End User
6 North America
6.1 North America Crisaborole by Countries
6.1.1 North America Crisaborole Sales by Countries
6.1.2 North America Crisaborole Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Crisaborole by Product
6.3 North America Crisaborole by End User
7 Europe
7.1 Europe Crisaborole by Countries
7.1.1 Europe Crisaborole Sales by Countries
7.1.2 Europe Crisaborole Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Crisaborole by Product
7.3 Europe Crisaborole by End User
8 Asia Pacific
8.1 Asia Pacific Crisaborole by Countries
8.1.1 Asia Pacific Crisaborole Sales by Countries
8.1.2 Asia Pacific Crisaborole Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Crisaborole by Product
8.3 Asia Pacific Crisaborole by End User
9 Central & South America
9.1 Central & South America Crisaborole by Countries
9.1.1 Central & South America Crisaborole Sales by Countries
9.1.2 Central & South America Crisaborole Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Crisaborole by Product
9.3 Central & South America Crisaborole by End User
10 Middle East and Africa
10.1 Middle East and Africa Crisaborole by Countries
10.1.1 Middle East and Africa Crisaborole Sales by Countries
10.1.2 Middle East and Africa Crisaborole Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Crisaborole by Product
10.3 Middle East and Africa Crisaborole by End User
11 Company Profiles
11.1 Tapi Teva
11.1.1 Tapi Teva Company Details
11.1.2 Company Business Overview
11.1.3 Tapi Teva Crisaborole Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Tapi Teva Crisaborole Products Offered
11.1.5 Tapi Teva Recent Development
11.2 Neuraxpharm
11.2.1 Neuraxpharm Company Details
11.2.2 Company Business Overview
11.2.3 Neuraxpharm Crisaborole Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Neuraxpharm Crisaborole Products Offered
11.2.5 Neuraxpharm Recent Development
11.3 VIRUJ PHARMA
11.3.1 VIRUJ PHARMA Company Details
11.3.2 Company Business Overview
11.3.3 VIRUJ PHARMA Crisaborole Sales, Revenue and Gross Margin (2017-2020)
11.3.4 VIRUJ PHARMA Crisaborole Products Offered
11.3.5 VIRUJ PHARMA Recent Development
11.4 Synergy Pharmaceutical
11.4.1 Synergy Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Synergy Pharmaceutical Crisaborole Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Synergy Pharmaceutical Crisaborole Products Offered
11.4.5 Synergy Pharmaceutical Recent Development
11.5 Ausun Pharmaceutical
11.5.1 Ausun Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Ausun Pharmaceutical Crisaborole Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Ausun Pharmaceutical Crisaborole Products Offered
11.5.5 Ausun Pharmaceutical Recent Development
12 Future Forecast
12.1 Crisaborole Market Forecast by Regions
12.1.1 Global Crisaborole Sales Forecast by Regions 2021-2027
12.1.2 Global Crisaborole Revenue Forecast by Regions 2021-2027
12.2 Crisaborole Market Forecast by Product
12.2.1 Global Crisaborole Sales Forecast by Product 2021-2027
12.2.2 Global Crisaborole Revenue Forecast by Product 2021-2027
12.3 Crisaborole Market Forecast by End User
12.4 North America Crisaborole Forecast
12.5 Europe Crisaborole Forecast
12.6 Asia Pacific Crisaborole Forecast
12.7 Central & South America Crisaborole Forecast
12.8 Middle East and Africa Crisaborole Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Crisaborole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
